Search

Your search keyword '"Hide, Michihiro"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Hide, Michihiro" Remove constraint Author: "Hide, Michihiro" Publication Year Range This year Remove constraint Publication Year Range: This year
19 results on '"Hide, Michihiro"'

Search Results

1. Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus

2. A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema

5. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

7. The Bruton’s Tyrosine Kinase Inhibitor Remibrutinib Exhibits No Impact on Serum Immunoglobulin Levels: Insights from Chronic Spontaneous Urticaria (P10-6.018)

8. Safety of Remibrutinib Across Immune-mediated Diseases Supports Development in Multiple Sclerosis (P8-6.015)

9. Survey of hereditary angioedema episodes and quality of life impairment through a patient-participatory registry

11. Efficacy of Remibrutinib in Patients With Chronic Spontaneous Urticaria With or Without Prior Exposure to Biologics in the Phase 3 REMIX-1 and REMIX-2 Studies

12. CRUSE®—An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria

14. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

15. Long term safety and efficacy of ligelizumab in the treatment of Japanese patients with Chronic Spontaneous Urticaria

16. Decreased intracellular histamine concentration and basophil activation in anaphylaxis

17. Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study

18. Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation.

19. CRUSE ® -An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria.

Catalog

Books, media, physical & digital resources